Halpern AB, Othus M, Huebner EM, Scott BL, Hendrie PC, Percival M-EM, Becker PS, Smith HA, Oehler VG, Orozco JJ, Cassaday RD, Gardner KM, Chen TL, Buckley SA, Orlowski KF, Anwar A, Estey EH, Walter RB. Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms. Haematologica [Internet]. 2019Mar.31 [cited 2026Nov.11];104(4):e143-e146. Available from: https://haematologica.org/article/view/8865